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Polyethylenimine (PEI) is a well-known cationic polymer that has gained recent 
attention as a transfection and transduction agent. However; it is extremely cytotoxic 
in many cell lines because of its high surface charge (about +40 mV), non-
biodegradability and non-biocompatibility. Other drawbacks of this polymer include, 
low duration of expression, non-specific cell uptake and instability in blood 
circulation. To enhance Polyethyleneimine biocompatibility, the graft pegylated 
copolymer was synthesized. To target cancer liver cells, two targeting ligands folic 
acid and galactose (lactobionic acid) were attached with graft Pegylated copolymer 
to increase specifically the entrance of this new targeted copolymer to cancer liver 
cells, because the folic acid and lactobionic acid receptors are over expressed only 
on human hepatocyte carcinoma. The composition of this new conjugated copolymer 
was characterized using 
1
H-NMR spectra. Its molecular weight and zeta potential 
were compared to polyethyleneimine. To study the entrance of this targeted carrier 
to human hepatocyte carcinoma (HepG2), fluoresceine isothiocyanate (FITC) as a 
model drug was conjugated to this novel carrier and the emission of green 
fluorescent was determined from three cell lines (HEK293, KB and HepG2) and 
compared with  fluoresceine isothiocyanate alone. 
Introduction: In recent years, there has been an enormous interest in the 
formulation of a targeted carrier for a specific population of cells, either locally or 
systematically. The targeted drug delivery system can be achieved by either non-
polymeric or polymeric carrier methods.  Novel drug delivery by non-polymeric 
carriers has been studied for years; however, the broad use of this system is affected 
by the limited size of material delivered, cytotoxicity and no targeting interaction to 
certain cells. Polymeric drug delivery carriers have become a promising alternative 
since the carriers could be synthesized with higher purity and quality degree and less 
immunogenic response than the viral and lipidic carriers for drug targeting. 
Methods and results:  First of all, pegylated polyethylenimine (PEG-g-PEI) was 
synthesized and then folate-PEG-g-PEI, folate-PEG-g-PEI-galactose was prepared 
and folate-PEG-g-PEI-galactose conjugated with Fluorescein isothiocyanat as a 
model drug.  
         To investigate transduction efficacy of FOL-PEG-g-PEI-GAL conjugated with 
FITC, as a drug model, the fluorescent activity was measured in transduced HepG2, 
HEK293 and KB cell lines and the results are monitored. 
As shown in Fig 1. the emission of green fluorescent had the following order:The 
intensity of green fluorescent light of HepG2> the intensity of green fluorescent light 









The Transduction efficacy was further quantified by flow cytometry. The ratios of 
Fluorescence- positive cells were 79%, 51% and 12% in HepG2, KB and HEK293 
respectively (Fig.1). The transduction of fluoresceine isothiocyanate alone was not 
noticeable in any cell lines. This could be due to its high aqueous solubility. 
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Fig 1. Efficacy of copolymer "FOL-PEG-g-PEI-GAL" conjugated with FITC in HepG2, 
HEK293T and KB cell lines detected by fluorescent images 
Conclusions: In this study, the FOL-PEG-g-PEI-GAL copolymer as a novel 
biocompatible polymer was synthesized for targeting cancer liver cells and 
characterized using 
1
H-NMR and FTIR. This new copolymer, FOL-PEG-g-PEI- 
GAL, showed improved degradation in PBS at 37ºC compared with PEI.  
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